Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic fibrosis treatment. Progress in that specialty area and two key drug approvals ...

Journavx works differently than other available medications, and its developer, the biotechnology juggernaut Vertex Pharmaceuticals, has positioned it as an important, non-opioid option for pain ...

TV antennas are having something of a renaissance in the U.S. Buoyed by the ever-increasing costs of cable and streaming subscriptions, and additional channels enabled by the advent of digital TV ...